The pursuit of optimal outcomes in cancer therapy in a new age of rationally designed target-based anticancer agents.

The pursuit of optimal outcomes in cancer therapy in a new age of rationally designed target-based anticancer agents.

Item
http://www.wikidata.org/entity/Q34112975
Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programmePhase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer.Tolerability of gefitinib in patients receiving treatment in everyday clinical practiceThe role of surrogate markers in the clinical development of antiretroviral therapy: a model for early evaluation of targeted cancer drugs.Yeast as a model system for anticancer drug discovery.Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium.Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities.Preclinical evaluation of radiolabelled nimotuzumab, a promising monoclonal antibody targeting the epidermal growth factor receptor.Gefitinib: a consideration of cost.A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors.
P2860

The pursuit of optimal outcomes in cancer therapy in a new age of rationally designed target-based anticancer agents.

Item
http://www.wikidata.org/entity/Q34112975
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The pursuit of optimal outcome ...... arget-based anticancer agents.
@ast
The pursuit of optimal outcome ...... arget-based anticancer agents.
@en
The pursuit of optimal outcome ...... arget-based anticancer agents.
@nl
type
label
The pursuit of optimal outcome ...... arget-based anticancer agents.
@ast
The pursuit of optimal outcome ...... arget-based anticancer agents.
@en
The pursuit of optimal outcome ...... arget-based anticancer agents.
@nl
prefLabel
The pursuit of optimal outcome ...... arget-based anticancer agents.
@ast
The pursuit of optimal outcome ...... arget-based anticancer agents.
@en
The pursuit of optimal outcome ...... arget-based anticancer agents.
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P478
P577
P6179
P698
P356
P1433
P1476
The pursuit of optimal outcome ...... arget-based anticancer agents.
@en
P2093
P2888
P304
P31
P356
10.2165/00003495-200060001-00001
P478
P577
P6179
P698